Know what’s really happening at
Pinnacle Medicines before you sign on.
- On the roadmap
- Biotech
- AI Drug Discovery
- Peptide Therapeutics
Pinnacle Medicines is an early-stage biotech combining AI-driven and structure-based drug design to discover and develop peptide therapeutics for unmet medical needs. Backed by top-tier investors and growing rapidly, the company represents a notable bet on next-generation peptide modalities including oral delivery.
How we do it.
Most "AI market intel" is a summarized crawl of press releases. This Altis research is built from our knowledge graph of sector expert calls, synthesized with public sources.
Pinnacle Medicines
- Series B Raised
- $89M
- Total Funding
- $89.6M
- Year Founded
- 2024
- Employee Count
- 21
- Headquarters
- Doylestown, Pennsylvania, United States
- Company Size Range
- 11-50
- Funding Rounds
- 2
Press reported
Altis Verified
What's in the report
Most "AI market intel" is a summarized crawl of press releases. This is what customers, competitors, and former employees actually told us.
Market Overview
Market structure, where the company sits, and growth drivers.
- market map
- Biotech landscape
- Biotech growth rate
- CAGR
Total Addressable Market
Bottom-up TAM / SAM / SOM.
- Pinnacle Medicines TAM
- Biotech market size
- market opportunity
Company Overview
What the company does and how it operates.
- what does Pinnacle Medicines do
- Pinnacle Medicines product
- business model
Product / Go-to-Market
Product, GTM motion, ICP, and who buys.
- Pinnacle Medicines customers
- who uses Pinnacle Medicines
- Pinnacle Medicines ICP
- go-to-market
Competitive Dynamics
The Altis Market Map and the Altis Win-Rate Index.
- Pinnacle Medicines competitors
- Pinnacle Medicines alternatives
- who competes with Pinnacle Medicines
- Pinnacle Medicines win rate
Customer Signals
Retention, satisfaction, and win/loss signals.
- Pinnacle Medicines reviews
- Pinnacle Medicines NRR
- Pinnacle Medicines churn
- current customers
- switching costs
Investment Debates
Investment thesis, moat, bull/bear, and key risks.
- Pinnacle Medicines investment thesis
- Pinnacle Medicines moat
- bull case bear case
- Pinnacle Medicines risk factors
Monetization & Financials
Business model, revenue model, and unit economics.
- Pinnacle Medicines ARR
- Pinnacle Medicines revenue
- Pinnacle Medicines valuation
- unit economics
Team and culture
Founders, leadership, and org.
- Pinnacle Medicines founders
- Pinnacle Medicines CEO background
- leadership team
- headcount
Trusted by
Ready to see the full picture?
Analysis based on Altis structured company profile data and public funding records.